114 related articles for article (PubMed ID: 1691227)
1. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy.
Holmes CH; Simpson KL; Wainwright SD; Tate CG; Houlihan JM; Sawyer IH; Rogers IP; Spring FA; Anstee DJ; Tanner MJ
J Immunol; 1990 Apr; 144(8):3099-105. PubMed ID: 1691227
[TBL] [Abstract][Full Text] [Related]
2. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
[TBL] [Abstract][Full Text] [Related]
3. HLA Class I protein expression in the human placenta.
Blaschitz A; Hutter H; Dohr G
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
[TBL] [Abstract][Full Text] [Related]
4. Complement regulatory proteins in early human fetal life: CD59, membrane co-factor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver.
Simpson KL; Houlihan JM; Holmes CH
Immunology; 1993 Oct; 80(2):183-90. PubMed ID: 7505254
[TBL] [Abstract][Full Text] [Related]
5. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.
Coyne KE; Hall SE; Thompson S; Arce MA; Kinoshita T; Fujita T; Anstee DJ; Rosse W; Lublin DM
J Immunol; 1992 Nov; 149(9):2906-13. PubMed ID: 1383332
[TBL] [Abstract][Full Text] [Related]
6. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland.
Lass JH; Walter EI; Burris TE; Grossniklaus HE; Roat MI; Skelnik DL; Needham L; Singer M; Medof ME
Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1136-48. PubMed ID: 1693916
[TBL] [Abstract][Full Text] [Related]
7. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
[TBL] [Abstract][Full Text] [Related]
8. Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes.
Kinoshita T; Medof ME; Nussenzweig V
J Immunol; 1986 May; 136(9):3390-5. PubMed ID: 2420889
[TBL] [Abstract][Full Text] [Related]
9. The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.
Mold C; Walter EI; Medof ME
J Immunol; 1990 Dec; 145(11):3836-41. PubMed ID: 1700997
[TBL] [Abstract][Full Text] [Related]
10. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
Simpson KL; Jones A; Norman S; Holmes CH
Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
[TBL] [Abstract][Full Text] [Related]
11. Differentiation-dependent changes in human trophoblast expression of decay-accelerating factor are modulated by 3',5' cyclic adenosine monophosphate.
Zarkadis IK; Omigbodun A; Forson A; Ziolkiewicz P; Kinoshita T; Lambris JD; Coutifaris C
J Soc Gynecol Investig; 1997; 4(1):47-53. PubMed ID: 9051634
[TBL] [Abstract][Full Text] [Related]
12. Expression of decay-accelerating factor (CD55) of the complement system on human spermatozoa.
Cervoni F; Oglesby TJ; Fénichel P; Dohr G; Rossi B; Atkinson JP; Hsi BL
J Immunol; 1993 Jul; 151(2):939-48. PubMed ID: 7687624
[TBL] [Abstract][Full Text] [Related]
13. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
Iwata K; Seya T; Ariga H; Nagasawa S
J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
[TBL] [Abstract][Full Text] [Related]
14. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
[TBL] [Abstract][Full Text] [Related]
15. Complement activation induces the expression of decay-accelerating factor on human mesangial cells.
Shibata T; Cosio FG; Birmingham DJ
J Immunol; 1991 Dec; 147(11):3901-8. PubMed ID: 1719094
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
[TBL] [Abstract][Full Text] [Related]
17. Cells of the fetomaternal interface: their role in the maintenance of viviparous pregnancy.
Lala PK; Kearns M; Colavincenzo V
Am J Anat; 1984 Jul; 170(3):501-17. PubMed ID: 6475813
[TBL] [Abstract][Full Text] [Related]
18. Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.
Guo B; Ma ZW; Li H; Xu GL; Zheng P; Zhu B; Wu YZ; Zou Q
Clin Immunol; 2008 Aug; 128(2):155-63. PubMed ID: 18502181
[TBL] [Abstract][Full Text] [Related]
19. Decay accelerating factor regulates complement activation on glomerular epithelial cells.
Quigg RJ; Nicholson-Weller A; Cybulsky AV; Badalamenti J; Salant DJ
J Immunol; 1989 Feb; 142(3):877-82. PubMed ID: 2464030
[TBL] [Abstract][Full Text] [Related]
20. A high m.w. form of decay-accelerating factor (DAF-2) exhibits size abnormalities in paroxysmal nocturnal hemoglobinuria erythrocytes.
Kinoshita T; Rosenfeld SI; Nussenzweig V
J Immunol; 1987 May; 138(9):2994-8. PubMed ID: 2437202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
